Search research articles
Contact Us
Filters
Showing results (1331-1340 of 1,457) with videos related to
Page
of 146
Sort By:
Journal of Neuro-Oncology
|
October 13, 2006
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme
Morris D Groves, Vinay K Puduvalli, Susan M Chang, et al.
Plos One
|
March 3, 2012
MCP1 SNPs and pulmonary tuberculosis in cohorts from West Africa, the USA and Argentina: lack of association or epistasis with IL12B polymorphisms
Digna R Velez Edwards, Alessandra Tacconelli, Christian Wejse, et al.
Neuro-Oncology Advances
|
November 25, 2020
Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02
Huanwen Chen, John Kuhn, Kathleen R Lamborn, et al.
American Journal of Medical Genetics. Part A
|
November 15, 2006
Phenotypic definition of Chiari type I malformation coupled with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9 and 15
Abee L Boyles, David S Enterline, Preston H Hammock, et al.
Neuro-Oncology
|
October 31, 2019
Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas
Victor Ruiz-Rodado, Tathiane M Malta, Tomohiro Seki, et al.
Neuro-Oncology
|
December 21, 2016
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813
Susan Chang, Peixin Zhang, J Gregory Cairncross, et al.
Neuro-Oncology
|
March 22, 2008
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas
Kathleen R Lamborn, W K Alfred Yung, Susan M Chang, et al.
Neuro-Oncology
|
March 1, 2021
A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma
Paul D Brown, Caroline Chung, Diane D Liu, et al.
Molecular Autism
|
January 14, 2014
Exome sequencing of extended families with autism reveals genes shared across neurodevelopmental and neuropsychiatric disorders
Holly N Cukier, Nicole D Dueker, Susan H Slifer, et al.
Elife
|
June 2, 2023
Defining function of wild-type and three patient-specific <i>TP53</i> mutations in a zebrafish model of embryonal rhabdomyosarcoma
Jiangfei Chen, Kunal Baxi, Amanda E Lipsitt, et al.
Page
of 146
Search research articles
Search
Showing results (1331-1340 of 1,457) with videos related to
Sort By:
Page
of 146
Journal of Neuro-Oncology
|
October 13, 2006
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme
Morris D Groves, Vinay K Puduvalli, Susan M Chang, et al.
Plos One
|
March 3, 2012
MCP1 SNPs and pulmonary tuberculosis in cohorts from West Africa, the USA and Argentina: lack of association or epistasis with IL12B polymorphisms
Digna R Velez Edwards, Alessandra Tacconelli, Christian Wejse, et al.
Neuro-Oncology Advances
|
November 25, 2020
Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02
Huanwen Chen, John Kuhn, Kathleen R Lamborn, et al.
American Journal of Medical Genetics. Part A
|
November 15, 2006
Phenotypic definition of Chiari type I malformation coupled with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9 and 15
Abee L Boyles, David S Enterline, Preston H Hammock, et al.
Neuro-Oncology
|
October 31, 2019
Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas
Victor Ruiz-Rodado, Tathiane M Malta, Tomohiro Seki, et al.
Neuro-Oncology
|
December 21, 2016
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813
Susan Chang, Peixin Zhang, J Gregory Cairncross, et al.
Neuro-Oncology
|
March 22, 2008
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas
Kathleen R Lamborn, W K Alfred Yung, Susan M Chang, et al.
Neuro-Oncology
|
March 1, 2021
A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma
Paul D Brown, Caroline Chung, Diane D Liu, et al.
Molecular Autism
|
January 14, 2014
Exome sequencing of extended families with autism reveals genes shared across neurodevelopmental and neuropsychiatric disorders
Holly N Cukier, Nicole D Dueker, Susan H Slifer, et al.
Elife
|
June 2, 2023
Defining function of wild-type and three patient-specific <i>TP53</i> mutations in a zebrafish model of embryonal rhabdomyosarcoma
Jiangfei Chen, Kunal Baxi, Amanda E Lipsitt, et al.
Page
of 146